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Naive T lymphocytes are activated through 
their TCRs by peptide–MHC complexes dis-
played on dendritic cells in secondary lymphoid 
tissue (1). Upon activation, T cells undergo 
rapid proliferation, diff  erentiating into eff  ectors
capable of migrating into sites of   infection 
and producing antimicrobial lymphokines (2). 
A contraction phase then results in the elimina-
tion of the vast majority of T cells, leaving be-
hind a stable population of memory cells (2). 
Two types of memory T cells have been de-
fi  ned based on expression of the cell surface 
homing receptors CD62L and CCR7 (3–6). 
Central–memory cells, which express both 
CD62L and CCR7, are located primarily in 
secondary lymphoid organs and produce IL-2 
and proliferate well when exposed to antigen 
but are poor producers of eff  ector lymphokines 
such as IL-4 or IFN-γ. Eff  ector–memory cells 
do not express either CD62L or CCR7, reside 
in secondary lymphoid organs and nonlym-
phoid tissue, produce eff  ector cytokines effi   -
ciently, and may not proliferate as well as 
central–memory cells (7), although this latter 
feature remains controversial (8). Eff  ector–
mem  ory cells may benefi  t the host by eliminat ing 
microbes quickly within nonlymphoid tissue, 
whereas central–memory cells are thought to 
replenish the memory cell pool.
The conditions that favor the generation of 
central– and eff  ector–memory cells during the 
primary immune response are unknown. Here 
we tested the possibility that asynchronous 
  exposure to antigen as CD4+ T cells recirculate 
through antigen-containing lymphoid organs is 
one determining factor. Most infections and vac-
cinations result in deposition of foreign antigen 
in local tissues, which in turn leads to antigen 
presentation within a subset of the secondary 
lymphoid organs. For example, subcutaneous in-
jection of antigen results in antigen presentation 
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exclusively in the lymph nodes that drain the injection site (9).
Because naive T lymphocytes migrate randomly through 
all secondary lymphoid organs (10, 11), this creates a situa-
tion in which antigen-specifi  c T cells that happen to reside 
in the   antigen-draining lymph node at the time of   antigen 
exposure will be activated immediately, whereas others that 
enter this lymph node from other parts of the body will 
be activated later. These “resident” and “late-arriving” T cells 
are likely to experience diff  erent levels of TCR and CD28 
stimulation caused by changes in peptide–MHC and costimu-
latory ligand densities that occur over time after antigen enters 
the body. Diff  erences in activation signal strength could then 
infl  uence the numbers of eff  ector and central–memory cells 
that are   produced (12).
We addressed the role of late-arriving T cells on cell divi-
sion and memory phenotype by preventing these cells from 
entering antigen-draining lymph nodes. The results demon-
strate that the late arrivers account for a substantial propor-
tion of the total antigen-specifi  c CD4+ T cell population that 
accumulates during the primary response. These late arrivers 
are enriched for cells with the central–memory cell pheno-
type and exhibit superior proliferation during the secondary 
immune response.
RESULTS
Kinetics of T lymphocyte entry and egress 
from skin-draining lymphoid tissue
Before attempting to measure the contribution of late-
  arriving CD4+ T cells during a primary response to a sub-
cutaneous antigen, it was fi  rst necessary to characterize the 
recirculation pattern of a defi  ned population of naive CD4+ 
T cells through skin-draining lymph nodes. Naive CD4+ T 
cells from TEa TCR transgenic mice specifi  c for a peptide 
from the I-Eα MHC II molecule (pEα) bound to I-Ab were 
injected intravenously into normal C57BL/6 (B6) recipient 
mice, which lack the relevant antigen. The rate at which 
the TEa cells appeared in the cervical lymph nodes was then 
measured by fl  ow cytometry. The naive TEa T cells entered 
the lymph nodes of the recipient quickly, achieving a half-
maximal level after only 2 h (Fig. 1 A). As expected, very few 
TEa T cells were found in the cervical lymph nodes of mice 
that received anti-CD62L antibody before the cell transfer 
(Fig. 1 B), because CD62L is required for naive T cell migra-
tion from the blood into lymph nodes via high endothelial 
venules (13). This interpretation was supported by the fi  nd-
ing that anti-CD62L antibody-treated recipients had elevated 
numbers of TEa cells in their spleens (Fig. 1 B), as naive 
T cell migration into the spleen does not depend on CD62L 
(14). Thus, anti-CD62L antibody treatment was eff  ective at 
preventing transferred naive CD4+ T cells from homing to 
lymph nodes.
The eff  ectiveness of anti-CD62L antibody at blocking na-
ive T cell entry into lymph nodes was exploited to   determine 
the time that naive T cells spend in lymph nodes. Naive TEa 
T cells were injected intravenously into normal mice and then 
given 24 h to reach the steady-state level of recirculation. 
Anti-CD62L antibody was then injected to prevent any TEa 
T cells that left a lymph node from entering any other lymph 
node. The number of TEa T cells present in the cervical 
lymph nodes declined sharply after injection of anti-CD62L 
antibody, whereas the number of TEa cells in untreated con-
trols did not change over a 6-d period (Fig. 1 C). About 24 h 
Figure 1.  Naive CD4+ T cell traffi  cking in skin-draining lymph nodes. 
(A) Naive TEa CD4+ T cells in the cervical lymph nodes of recipient mice 
were monitored at different times after injection of 106 cells. CD4 and 
CD90.1 were used to identify TEa T cells, and percentages relative to endog-
enous CD4+ T cells are shown. (B) Mice were given control Ig or anti-CD62L 
antibody, and shortly thereafter TEa T cells. The number of TEa cells in the 
cervical lymph nodes or spleen 5 d after transfer are shown. (C) Mice re-
ceived TEa T cells, and the next day control Ig (●) or anti-CD62L antibody (○). 
The number of TEa cells in the cervical lymph nodes over time is shown. 
(D) CD62L expression on endogenous CD4+ T cells at the indicated times 
after treatment with anti-CD62L antibody are shown (white histograms). 
Gray histograms show CD62L expression on CD4+ T cells from untreated 
  animals. Error bars in A and C represent standard deviation (n = 2). 
Data are representative of three independent experiments.JEM VOL. 203, April 17, 2006  1047
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was required for half of the TEa cells that were initially pre-
sent to exit the lymph nodes of anti-CD62L–treated mice. 
Collectively, these data suggest that naive lymphocytes enter 
lymph nodes rapidly from the blood, in a CD62L-dependent 
fashion, and spend about a day in this location before return-
ing to the circulation. As shown by several previous stud-
ies (14–16), we found that a single injection of anti-CD62L 
antibody led to eff  ective removal of CD62L from the T cell 
surface for  12–14 d (Fig. 1 D) and blocked the entry of 
naive CD4+ T cells into lymph nodes during this time frame 
(unpublished data). Thus, our subsequent analyses of the ef-
fects of CD62L blockade were limited to this time period.
Late-arriving T cells contribute to a localized primary 
immune response
Anti-CD62L antibody treatment was then used to assess the 
contribution of late-arriving T cells to a localized primary 
immune response. The idea was that administration of anti-
CD62L antibody immediately before immunization of nor-
mal mice that had already received TCR transgenic T cells 
would not interfere with the response of the transferred 
T cells that resided in the draining lymph nodes at the time of 
immunization, but would prevent the participation of trans-
ferred T cells that would normally have entered these lymph 
nodes from other secondary lymphoid organs. To minimize 
deleterious eff  ects of intraclonal competition on activation 
(17) and memory cell formation (18), only 104 TEa cells were 
transferred, resulting in  10 cells in the deep cervical lymph 
nodes of each recipient under steady-state conditions (Fig. 
2 A). The next day, recipient mice were injected intraperi-
toneally with anti-CD62L or control Ig, and intradermally in 
the ear with 30 ng of a recombinant antigen EαRFP contain-
ing the Eα peptide (9), plus LPS as an adjuvant (19). 30 ng
was chosen because it produces peptide–MHC II com-
plexes in the draining lymph nodes for  10 d after injection 
  (unpublished data) as might be expected for many vaccines. 
TEa cells in the antigen-draining cervical lymph nodes of 
control Ig-treated mice increased 200-fold to a peak on day 6 
and then declined (Fig. 2, A and B) as reported in other pri-
mary CD4+ T cell responses (20, 21). Anti-CD62L antibody 
reduced the accumulation of TEa cells in the antigen-drain-
ing lymph nodes to  50 and 10% of the control levels on 
days 6 and 10, respectively (Fig. 2 B). The local nature of this 
response was indicated by the fi  nding that TEa cells increased 
only 10-fold in the nondraining mesenteric lymph nodes of 
control Ig-treated mice and not at all in the mesenteric lymph 
nodes of anti-CD62L–treated mice (Fig. 2 C). The complete 
lack of accumulation of TEa cells in the nondraining mesen-
teric lymph nodes of anti-CD62L–treated mice suggested that 
the 10-fold increase in control mice was caused by TEa cells 
that proliferated in the draining lymph nodes but retained 
CD62L and then migrated to the mesenteric lymph nodes. 
Together, these data show that late-arriving CD4+ T cells, 
either naive cells or CD62L+ cells that were activated in the 
Figure 2.  The contribution of late-arriving T cells to the local 
  immune response in skin-draining lymph nodes. (A) 10,000 TEa T cells 
were injected into recipient mice, which were then injected with PBS 
(middle) or 30 ng of EαRFP plus LPS in the ear (right). 6 d after antigen 
injection, cervical lymph node cells from these mice, or mice that did not 
receive TEa cells (left), were identifi  ed as CD4+ and CD90.1+ cells. Contour 
plots of CD4 versus CD90.1 on CD11b−, B220−, and CD8α− cells are 
shown. (B) Recipients of 104 TEa cells were injected with control Ig (●) or 
anti-CD62L antibody (○) followed shortly thereafter by 30 ng of EαRFP 
plus LPS in the ear. Transgenic cells were detected as described in A in the 
cervical (B) or mesenteric lymph nodes (C) of the treated mice at 
the indicated times. (D) CFSE histograms of TEa T cells in the cervical 
lymph nodes from control or anti-CD62L–treated mice shown in B. 
(E) Numbers of cells that had divided one to six times (using gates from D) 
from mice treated with control Ig (●) or anti-CD62L (○). The gate used to 
identify cells that had divided one to six times was based on the intensity 
of unstained endogenous CD4+ T cells, and the CFSE level of undivided 
TEa cells from unprimed animals. (F) CFSE histograms of TEa T cells from 
cervical lymph nodes and spleens of mice 6 d after immunization with 
EαRFP plus LPS are shown. Gray histograms represent naive TEa T cells 
from unprimed mice. All error bars represent SD (n = 2). Data are repre-
sentative of three independent experiments.1048  T CELL RECIRCULATION AND MEMORY | Catron et al.
draining lymph nodes and then left and returned, contribute 
substantial numbers of cells to the total pool of antigen-
specifi  c CD4+ T cells that expand in the lymph nodes draining 
a subcutaneous antigen injection site.
Cell division history
The CFSE dye dilution method was used in an attempt to 
identify the late-arriving T cells based on the assumption that 
these cells might be expected to divide fewer times than the 
resident T cells due to increased intraclonal competition or 
reduced levels of antigen. The TEa cells in the cervical lymph 
nodes of mice that received EαRFP and control Ig 6 d earlier 
were heterogeneous with respect to cell division history as 
indicated by the fact that  12% had divided one to six times 
(Fig. 2 D). These less divided cells became a larger percentage 
of the total on day 10 (Fig. 2 D), perhaps as a result of the 
most divided cells migrating out of the lymph nodes (22, 23). 
The less divided population was greatly reduced in the cervi-
cal lymph nodes of mice that received EαRFP and anti-
CD62L antibody (Fig. 2, D and E). The large reduction of 
the less divided cells by anti-CD62L antibody treatment is 
consistent with the idea that the less divided cells in the con-
trol Ig-treated mice were T cells that migrated into the drain-
ing lymph node after antigen injection and underwent their 
divisions in this location. However, it was possible that these 
cells had actually divided in some other location, perhaps in 
response to small amounts of antigen leaking from the injec-
tion site into the blood, and then entered the draining lymph 
nodes. This possibility was tested by examining the CFSE 
profi  les of TEa cells in the spleen, which is the site of im-
mune responses to blood-borne antigens. The small number 
of TEa cells in the spleen 6 d after antigen injection consisted 
of two populations—one that had not divided at all and thus 
consisted of naive cells, and one that had divided more than 
six times. Less than 1% of the TEa cells in the spleen at this 
time had the one to six cell division history characteristic of 
the less divided cells in the draining cervical lymph nodes 
(Fig. 2 F). The absence of these intermediates in the spleen 
ruled out the possibility that the TEa cells in the draining 
lymph nodes with the one to six cell division history under-
went these divisions in the spleen and then migrated to the 
draining lymph nodes. It also suggests that most of the cells 
with the one to six cell division history in the draining lymph 
nodes are not leaving this location at a high rate during the 
fi  rst week of the response. Collectively, these results suggest 
that the less divided cells in the draining cervical lymph nodes, 
that were lost after anti-CD62L treatment, were cells that 
entered this location late after antigen injection and divided 
there. Conversely, the highly divided cells that appeared in 
the spleen most likely underwent their divisions in the drain-
ing lymph nodes and then migrated to the spleen.
If the less divided cells identifi  ed in Fig. 2 D were truly 
late arrivers, then TEa cells transferred into mice at late times 
after EαRFP injection should display the less divided pattern 
because all of the cells in the draining lymph nodes in this 
case would have entered after antigen injection. As shown in 
Fig. 3 B, 43% of the TEa cells transferred into mice injected 
intradermally 3 d earlier with EαRFP, and assayed 6 d after 
transfer, had divided one to six times (Fig. 3 B; sum of middle 
gates) compared with 17% of the TEa cells that were in mice 
at the time of EαRFP injection (Fig. 3 C). Thus, forcing all of 
the TEa cells to enter the draining lymph nodes after antigen 
injection increased the fraction of the cells that divided one to 
six times, supporting the possibility that the less divided cells, 
that were eliminated by anti-CD62L antibody treatment, 
were late arrivers. Notably, most of the TEa cells that divided 
after transfer into mice that were injected with EαRFP 3 d 
earlier retained expression of CD62L, even those that divided 
more than six times. (Fig. 3 B). The late-arriving TEa cells 
with a one to six cell division history from the draining lymph 
nodes of mice that were injected with antigen after T cell 
transfer also retained CD62L expression, whereas many of the 
cells that divided more than six times lost CD62L (Fig. 3 C). 
Therefore, late-arriving CD4+ T cells were less likely to lose 
CD62L than resident CD4+ T cells that were in the lymph 
nodes at the time of antigen injection.
Mechanism underlying the fewer cell divisions experienced 
by late-arriving T cells
The basis for the fewer cell divisions experienced by late-
arriving T cells was explored next. One possibility was that 
late-arriving T cells divided less because of competition with 
the much larger population of resident T cells that had al-
ready proliferated at an earlier time after antigen injection 
(17, 24–26). To test the eff  ects of intraclonal competition 
on late-arriving T cells, we designed a system in which two 
diff  erent populations of DO11.10 TCR transgenic CD4+ 
T cells specifi  c for ovalbumin peptide–I-Ad complexes could 
be monitored simultaneously. Naive CD90.2+ DO11.10 
cells were injected intravenously into normal BALB/c mice, 
which then received an intradermal injection of ovalbumin 
peptide plus LPS in the ear. Control mice received just the 
Figure 3.  Cell division history of late-arriving T cells. Mice were 
injected intradermally with PBS (A) or 30 ng EαRFP plus LPS (B) and 
given 104 CFSE-labeled TEa T cells 3 d later. TEa T cell division and CD62L 
expression in draining lymph nodes was analyzed 6 d after cell transfer. 
The contour plots display CFSE versus CD62L levels on CD4+, CD90.1+, 
CD11b−, B220−, CD8α− lymphocytes. Percentages of cells that had un-
dergone zero, one to six, or more than six divisions are shown according 
to their CD62L expression. (C) Other mice were given 104 CFSE-labeled TEa 
T cells fi  rst and then injected with EαRFP plus LPS and analyzed 6 d later. 
Data are representative of three independent experiments.JEM VOL. 203, April 17, 2006  1049
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intradermal injection of ovalbumin peptide plus LPS. 6 d 
later, both sets of mice were injected intravenously with 104 
CFSE-labeled naive CD90.1+ DO11.10 cells, and the fre-
quency of the CD90.1+ cells was measured 6 d later. The 
fi  rst population of unlabeled CD90.2+ cells served as a source 
of preexisting competitors that had already expanded to their 
maximal number in response to antigen, whereas the second 
population of CFSE-labeled CD90.1+ cells served as a source 
of late arrivers. As shown in Fig. 4 A, the majority of CFSE-
labeled CD90.1+ DO11.10 cells that were transferred into 
antigen-primed recipients that did not receive competitors 
displayed the heterogeneous cell division history character-
istic of late-arriving T cells. When transferred into antigen-
primed mice that already contained an expanded population 
of CD90.2+ DO11.10 cells, the CFSE-labeled CD90.1+ 
DO11.10 cells divided on average one time less (Fig. 4 A) 
and accumulated about half as well as they did in the absence 
of intraclonal competition (Fig. 4 C).
To rule out any role for endogenous OVA-specifi  c CD4+ 
T cells in the competition, the experiment was also done us-
ing RAG-defi  cient hemagglutinin (HA) TCR transgenic re-
cipients, in which all of the CD4+ T cells are specifi  c for a 
single infl  uenza HA peptide. CFSE dye dillution was not in-
formative in these recipients because of homeostatic prolifer-
ation by the DO11.10 cells in the absence of OVA injection 
(unpublished data). However, CD90.1+ DO11.10 cells that 
were transferred into OVA-injected HA TCR transgenic 
  recipients of competing CD90.2+ DO11.10 cells expanded 
2–3-fold less than CD90.1+ DO11.10 cells that were trans-
ferred into OVA-injected HA TCR transgenic recipients that 
did not receive competitors (Fig. 4, B and C). Thus, intraclonal 
competition with early-arriving T cells probably accounts for 
some of the reduced cell division of late-arriving T cells.
We also tested the possibility that late-arriving T cells di-
vided less than resident T cells simply because the number of 
peptide–MHC II complexes remaining in the lymph nodes 
was lower at later times after antigen injection. This possibility 
could be tested directly after injection of EαRFP using the 
Y-Ae monoclonal antibody, which is specifi  c for the pEα–I-Ab
complexes recognized by TEa T cells (27). Previous work us-
ing this approach showed that dendritic cells are by far the most 
abundant producers of pEα–I-Ab complexes in the cervical 
lymph nodes after intradermal injection of EαRFP in the ear 
(9). As shown in Fig. 5, the percentage of CD11c+ dendritic 
cells that displayed pEα–I-Ab complexes peaked in the draining 
lymph nodes within 24 h after intradermal injection of EαRFP 
and then declined rapidly over the next 24 h. Thus, TEa cells 
that entered these lymph nodes after 48 h would be exposed to 
fewer pEα–I-Ab complexes than those residing in the lymph 
node at the time of antigen injection, providing a likely expla-
nation for the reduced number of cell divisions experienced by 
the late-arriving population.
Relationship between clonal frequency and antigen dose
The reduced cell division history and retention of CD62L 
raised the possibility that late-arriving CD4+ T cells give rise 
to central–memory cells. We wanted to test this possibility by 
purifying late arrivers via cell sorting based on their CFSE 
profi  le and then transferring these cells into new recipients. 
However, because so few TEa cells with the one to six cell 
division history were present in the draining lymph modes of 
mice that received 104 TEa cells and then EαRFP, it was 
Figure 4.  Late-arriving T cells and intraclonal competition. BALB/c 
mice (A) or RAG-defi  cient HA TCR transgenic mice (B) received 104 
CD90.2+ DO11.10 T cells (competitors) or no cells at all, followed by an 
intradermal injection of OVA plus LPS the next day. 6 d after antigen 
injection, all mice received 104 CFSE-labeled CD90.1+ DO11.10 T cells 
(late arrivers). The antigen-draining cervical lymph nodes were analyzed 
6 d after transfer. In BALB/c recipients, CD90.1 and CFSE levels were 
measured on CD4+, KJ1-26+, CD11b−, B220− lymphocytes. CFSE-labeled 
CD90.1+ DO11.10 T cells are visible in the top portion of both plots in 
A, whereas unlabeled CD90.2+ DO11.10 T cells are visible in the lower left 
corner of the right plot in A. CFSE dye dilution was not informative in 
the HA TCR transgenic recipients because of homeostatic proliferation of the 
transferred cells in the absence of OVA. Therefore, in these recipients, the 
competitor DO11.10 cells were identifi  ed as CD4+, CD90.1−, KJ1-26+, 
B220−, CD11b− cells (visible in the bottom box in the right panel of B), 
and the late-arriving DO11.10 cells as CD4+, CD90.1+, KJ1-26+, B220−, 
CD11b− cells (visible in the top box in both panels in B). The mean fold 
expansion (± SD, n = 2) for late arrivers in the absence (black bars) 
or presence (gray bars) of competitors was defi  ned as the number of late 
arrivers present on day 6 divided by the number present in mice that did 
not receive antigen, and is shown in C. Data are representative of three 
independent experiments.1050  T CELL RECIRCULATION AND MEMORY | Catron et al.
technically impossible to sort enough TEa memory cells for 
retransfer. An obvious solution to this problem was to gener-
ate the late arrivers in mice transferred with a much higher 
number of naive TEa cells. However, this solution was po-
tentially problematic because initial frequency is an important 
determinant of memory cell phenotype. For example, Marzo 
et al. showed that CD62Llow eff  ector–memory CD8+ T cells 
were not generated effi   ciently from an initially high number 
of naive cells (18). One explanation for this eff  ect was that 
intraclonal competition for peptide–MHC complexes pre-
vented the T cells from obtaining a strong enough TCR sig-
nal to become CD62Llow memory cells. If so, then it should 
be possible to produce effi   cient memory cell diff  erentiation 
from a large number of naive cells by increasing the antigen 
dose used for immunization.
We explored this possibility by testing the relationship 
between initial T cell frequency and antigen dose. As shown 
in Fig. 6 A, the fraction of highly divided, CD62Llow TEa 
cells present in the draining cervical lymph node 6 d after 
intradermal injection of 30 ng of EαRFP increased from 12 
to 43 to 64% as the number of transferred TEa cells decreased 
from 105 to 104 to 103. Similarly, the percentage of highly 
divided, CD62Llow TEa cells in mice that received 106 TEa 
cells increased from 33 to 42% as the EαRFP dose increased 
from 0.5 to 5 μg (Fig. 6 B). The fact that the cell division and 
CD62L profi  le achieved by the progeny of 104 cells exposed 
to 30 ng antigen closely resembled that achieved by 106 cells 
exposed to 5 μg was evidence that the inhibiting eff  ect of 
high T cell frequency on memory cell diff  erentiation could 
be overcome by increasing the antigen dose.
Late-arriving T cells and their impact on memory
The results in Fig. 6 showed that numerous CD62Llow cells 
could be produced from a large number of naive cells as long 
as a high dose of antigen was used for immunization. This 
fi  nding set the stage for sorting late-arriving T cells and deter-
mining whether or not these cells were capable of extensive 
proliferation during the secondary response as expected for 
central–memory cells. One million CFSE-labeled naive TEa 
T cells were transferred to naive mice, which were then im-
munized with a high dose of EαRFP (10 μg) in the ear. 17 d
were then allowed to pass during which the TEa cells un-
derwent the expansion and contraction phases of the primary 
response and stabilized numerically at the beginning of the 
memory phase (Fig. 7 A). As was observed at earlier times, 
the TEa cells recovered from the draining lymph nodes at 
this time were heterogenous with respect to CFSE dye dilu-
tion and CD62L and CCR7 expression (Fig. 7 B). The cells 
that divided one to six times expressed high levels of both 
molecules, which are phenotypic markers of central–memory 
cells (3), whereas the cells that divided 7 or more times con-
tained substantial populations of CD62Llow and/or CCR7low 
cells. The TEa cells were then sorted into two populations 
based upon their CFSE intensities: CFSE1–4, which consisted 
of late-arriving cells that had undergone one to four cell divi-
sions, and CFSE>6, which consisted of the dimmest CFSE-
labeled cells that had undergone at least seven divisions (Fig. 
7 C). CFSE1–4 cells were chosen instead of CFSE1–6 cells 
to rigorously eliminate highly divided cells. 2,000 cells of 
each type were then injected into separate sets of naive B6 
recipients, and a new sensitive magnetic bead enrichment tech-
nique described in Materials and methods was used to detect 
the transferred cells in spleen, lymph nodes, or lungs of the 
recipient mice.
A day after transfer, between 15 and 50 TEa cells were de-
tected in the spleen and lymph nodes of recipients of CFSE1–4 
or CFSE>6 cells (Fig. 7, D and E). Although, these were very 
small numbers, they were likely legitimate given that no such 
cells were detected in the spleen and lymph nodes from fi  ve 
mice that did not receive TEa cells (Fig. 7 D, top). The mice 
were then injected with EαRFP plus LPS intravenously to as-
sess the antigen-driven proliferation of the transferred cells 
throughout the body. 4 d later, TEa cells were detected in 
  recipients of either cell type at greater than the initial levels, 
indicating that both populations underwent antigen-driven 
proliferation (Fig. 7, D and E). However,  5–10 times more 
TEa cells were detected in the lymph nodes and spleens of 
  recipients of CFSE1–4 cells than the recipients of CFSE>6 cells 
(Fig. 7 E). Very small populations of TEa cells were detected 
in the lungs of recipients of both CFSE1–4 cells and CFSE>6 
cells. These results showed that the CFSE1–4 cells, which 
  divided fewer times in the primary response and had the pheno-
type of central–memory cells, were capable of greater prolif-
eration during a secondary response than the progeny of the 
more highly divided resident T cells.
DISCUSSION
Our results show that naive CD4+ T cells that enter the skin-
draining lymph nodes after antigen drains into this location 
contribute signifi  cantly to the total population of T cells that 
respond to a nonreplicating soluble antigen. This situation is 
a consequence of several features of lymphocyte recircula-
tion. Naive T cells migrate randomly from one secondary 
Figure 5.  Display of pE𝗂–MHC II complexes on dendritic cells in 
antigen-draining lymph nodes over time. 50 μg of EαRFP plus LPS (●) 
or LPS alone (○) was injected intradermally into the ears of mice, and the 
levels of pEα–MHC II complexes on CD11c+ dendritic cells were analyzed 
by Y-Ae staining at different times thereafter. The mean percentage of 
Y-Ae+ cells is shown. Data were pooled from multiple experiments and 
error bars represent SDs (n = 1–3).JEM VOL. 203, April 17, 2006  1051
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lymphoid tissue to another via the blood and lymphatic vas-
culature (11). Our results confi  rm earlier work showing that 
naive T cells enter lymphoid organs quickly from the blood 
(28) and then spend about a day in each lymphoid organ that 
they enter (10). It then follows that the population of naive 
T cells specifi  c for any given antigen will be randomly distrib-
uted among the spleen, several hundred lymph nodes, and 
mucosal lymphoid organs. Even if the rate of entry of naive 
T cells into infl  amed lymphoid organs increases several fold as 
suggested by Soderberg et al. (29), it would still take weeks 
for all T cells in this population to pass through any one of 
these organs. Therefore, when a foreign antigen is deposited 
in a local site, as would be the case in most infections or vac-
cinations, some antigen-specifi  c T cells will happen to be in 
the relevant secondary lymphoid organs at the time that anti-
gen is fi  rst presented, whereas others will continue to arrive 
in this location over time. Our results show that these late-
  arriving T cells account for at least half of the total population 
of antigen-specifi  c CD4+ T cells that accumulate in the drain-
ing lymph nodes in the fi  rst several weeks after intradermal 
injection of antigen.
Competition with the large population of T cells that ex-
panded early in the response contributed to the reduced cell 
division of late-arriving T cells. Previous work indicated that 
competition between naive T cells expressing the same TCR 
is related to competition for peptide–MHC complexes on 
APC (17). Notably, however, competition with T cells that 
proliferated earlier in the response only caused a 2–3-fold 
reduction in the expansion potential of the late arrivers. 
Thus, although competition was a restraining force on the 
activation of the late arrivers, it was not an absolute barrier. 
Competition may, therefore, favor the production of less-
  diff  erentiated memory cells by limiting, but not preventing 
the activation of late arrivers.
The declining number of dendritic cells that displayed rel-
evant peptide–MHC II complexes in these lymph nodes over 
time was likely another explanation for the reduced cell divi-
sion of late-arriving T cells. Notably, the late-arriving T cells 
with the one to six cell division history were easily detected 
in the draining lymph nodes even 1 wk after the relevant 
peptide–MHC II complexes disappeared. This fi  nding suggests 
that many of the late-arriving CD4+ T cells failed to execute 
the full proliferation program after antigen presentation 
ceased, consistent with the recent fi  nding that CD4+ T cells 
stopped dividing as soon as antigen presentation ceased (30).
Our results also showed that the late-arriving T cells from 
the primary response were much better at proliferating dur-
ing a secondary response than resident T cells. Jelley-Gibbs 
et al. (31) recently showed that naive virus antigen-specifi  c 
CD4+ T cells became more persistent memory cells after 
transfer into animals 1 wk after viral clearance than those 
transferred into animals at the time of infection. Since the 
cells transferred 1 wk into the infection would all be late ar-
rivers, these results provide further support for the possibility 
that long-lived memory cells can be preferentially generated 
from late-arriving T cells. Our results extend those of Jelley-
Gibbs et al. (31) by showing that late-arriving T cells are pro-
duced naturally by the combination of a locally presented 
antigen and the asynchronous circulation of naive T cells 
through the antigen-containing secondary lymphoid organs.
Our fi  nding that lowering the initial frequency of naive 
TEa cells increased the effi   ciency of their activation supports 
the conclusion of Marzo et al. (18) that the clonal frequency 
of naive T cells is an important determinant of memory cell 
fate. Our fi  ndings extend that work by showing that the inef-
fi  cient activation of large numbers of TCR transgenic T cells 
could be overcome by increasing the antigen dose. In addi-
tion, we found that the fraction of CD62Llow cells generated 
from a large number of naive cells after immunization with a 
high dose of antigen was maintained into the memory phase 
of response. Therefore, we conclude that adoptive transfer of 
large numbers of naive cells can be used to model the natural 
situation of low frequency as long as suffi   cient antigen is used 
for immunization.
Our approach identifi  ed two populations of cells in the 
draining lymph node after antigen injection: a late-arriving 
population with a one to six cell division history and a 
CD62Lhigh CCR7high phenotype that was blocked by anti-
CD62L treatment, and a resident population that was resis-
tant to CD62L blockade, experienced more than six cell 
divisions and contained a signifi  cant number of cells that had 
lost CD62L and/or CCR7. The fact that the progeny of late-
arriving T cells retained CD62L and CCR7 and the potential 
for extensive proliferation during the secondary response fi  ts 
Figure 6.  The relationship between clonal frequency and antigen 
dose. (A) Naive B6 recipient mice were injected with 103, 104, or 105 CFSE-
labeled TEa T cells and then immunized intradermally in each ear with 0 
or 30 ng of EαRFP plus LPS, or (B) 106 CFSE-labeled TEa T cells and then 
immunized with 0, 0.5, or 5 μg of EαRFP plus LPS. 4 (B) or 6 d (A) later, 
the TEa cells were identifi  ed as CD4+, CD90.1+, B220−, CD11b−, CD8α− 
lymphocytes and analyzed for CFSE dye dilution and CD62L expression. 
The percentage of CD62Llow cells with greater than six cell divisions is 
indicated on each contour plot. Data are representative of three indepen-
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with the possibility that these cells were central–memory cells 
(3). In contrast, the resident cells with CFSE cell division his-
tories greater than six had properties of eff  ector–memory 
cells, including a signifi  cant population of CD62Llow cells. 
The fact that these cells were not found in large numbers in 
the lungs after secondary transfer and priming of recipient 
mice argues against this possibility. However, it is possible 
that eff  ector–memory cells do not undergo division in the 
secondary response (7) and, therefore, may be diffi   cult to de-
tect, even in nonlymphoid tissue. This fraction also contained 
a population of CD62Lhigh cells and thus may have been con-
taminated with central–memory cells.
Finally, our results off  er a simple, anatomical explanation 
for how memory cells are generated from naive precursors. 
Eff  ector–memory cells may be generated from naive T cells 
that reside in the lymph nodes at the time that antigen fi  rst 
enters this location. These resident cells proliferate many 
times in response to a high density of peptide–MHC II and 
costimulatory ligands on dendritic cells, and in the process 
lose lymph node homing molecules and gain molecules re-
quired for migration to infl  amed tissues. At later times after 
antigen enters the body, other antigen-specifi  c T cells enter 
the draining lymph nodes and proliferate less because of com-
petition with previously activated resident T cells and expo-
sure to a lower density of peptide–MHC II and costimulatory 
ligands. The less intense activation of these cells allows reten-
tion of lymph node homing capacity and strong proliferative 
potential during secondary immune responses. Thus, it is pos-
sible that reduced cell division in the primary response caused 
by late arrival into secondary lymphoid organs constitutes a 
natural mechanism for generating central–memory T cells.
MATERIALS AND METHODS
Animals. 6–8-wk-old male B6 and BALB/c recipient mice were purchased 
from The Jackson Laboratory. DO11.10 BALB/c RAG-defi  cient (32) and 
TEa TCR transgenic mice (33) expressing the CD90.1 allele were bred on 
site. HA TCR transgenic (34) RAG-defi  cient BALB/c mice and DO11.10 
BALB/c RAG-defi  cient mice expressing the CD90.1 allele were obtained 
from Dr. Alex Khoruts (University of Minnesota). All mice were housed in 
a specifi  c pathogen-free facility at the University of Minnesota, and experiments 
were conducted according to federal and institutional guidelines and with 
Figure 7.  The relationship between cell division history and 
  memory cell potential. Naive B6 recipients injected with 106 CFSE-
 labeled  CD90.1+ TEa T cells were given 10 μg EαRFP plus LPS intrader-
mally in each ear. The mean number (± SD) of TEa T cells in the draining 
lymph nodes at the indicated times after antigen injection is shown in A. 
(B) 17 d after antigen injection, CD4+, CD90.1+ T cells from the draining 
lymph nodes were enriched by negative selection with magnetic beads 
and sorted into two populations: cells that had   undergone one to four 
divisions (CFSE1–4; right gate) and cells that had undergone more than 
six divisions (CFSE>6; left gate). CD62L and CCR7 levels on presorted cells 
are shown. (C) Post-sort analysis showed clear separation of the CFSE>6 
(white histogram) and CFSE1–4 (gray   histogram) cells. 2,000 cells of each 
type were then transferred into new naive B6 recipients. (D) 1 d after 
transfer (middle), or 1 d after transfer and 4 d after intravenous injection 
of EαRFP plus LPS (bottom), spleen, lymph nodes, and lungs were ana-
lyzed for the presence of TEa cells using the anti-CD90.1 magnetic bead 
enrichment technique (as described in Materials and methods). The con-
tour plots display CD90.1 versus TCR Vα2 expression on CD4+, B220−, 
CD11b−, CD8α−   lymphocytes, with TEa T cells shown in the box. A con-
tour plot from a mouse that did not receive TEa T cells is shown in the 
top panel of D as a negative control. (E) The mean number of TEa T cells 
in spleen (SPL) and lymph nodes (LN) on day 0 and spleen, lymph nodes, 
and lungs (LG) on day 4 after antigen challenge are shown. Error bars 
repre-sent SD (n = 2). Data are representative of at least three 
 independent  experiments.JEM VOL. 203, April 17, 2006  1053
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the approval of the University of Minnesota Institutional Animal Care and 
Use Committee.
Antigens and antibodies. OVA peptide 323–329 was purchased from 
Research Genetics. The EαRFP protein was purifi  ed from bacterial lysates 
using a Nickel resin His-Bind column (Novagen) as previously described (9). 
Contaminating endotoxin was removed using TritonX-114 phase separation 
(35). Anti–mouse CD62L was purifi  ed from ascites of the Mel-14 hybrid-
oma (American Type Culture Collection) using protein G–Sepharose. Con-
trol rat IgG was purchased from Sigma-Aldrich. Antibodies were injected 
intraperitoneally in a single dose of 250 μg per mouse.
Adoptive transfer. Pooled spleen and lymph node cells from naive TCR 
transgenic donor mice were used for adoptive transfer. In some cases, these 
cells were labeled before transfer with 5 μM CFSE (Molecular Probes) as 
previously described (36, 37).
TEa TCR transgenic cells from donor mice were identifi  ed by fl  ow 
  cytometry after staining of a small sample with FITC-labeled anti-CD4 
(eBioscience), PE-labeled anti-TCR Vα2, and PerCP-labeled anti-CD90.1 
(BD Biosciences) antibodies. The fraction of TEa cells identifi  ed in this 
sample was then used to calculate the desired number of TEa cells from 
an unlabeled sample to be transferred by intravenous injection into naive 
CD90.2+ B6 mice. Recipient mice were injected intradermally in the ear 
with 30 ng, 0.5, 5, or 10 μg of EαRFP. 1 μg LPS (List Biological) was used 
as an adjuvant for each ear injection. In some cases, mice were given an 
intraperitoneal injection of control or anti-CD62L antibody 15 min before 
antigen administration.
TEa T cells were detected in lymph node or spleen cell suspensions 
from recipient mice by staining with PE-labeled anti-CD4 and PerCP-
  labeled anti-CD90.1 (BD Biosciences) antibodies as previously described (9). 
CD62L was detected with an APC-labeled anti-CD62L antibody (eBiosci-
ence). Detection of CCR7 was accomplished using an ELC-Fc fusion pro-
tein (obtained from Jason Cyster, University of California-San Francisco, 
San Francisco, CA), followed by biotin-labeled anti–human Fc antibody 
(Jackson ImmunoResearch), and streptavidin-labeled APC. The number of 
transferred T cells was calculated by multiplying the frequency of CD90.1+, 
CD4+ cells by the number of live lymphocytes.
In some experiments two congenic DO11.10 CD4+ T cell popula-
tions, CD90.1+ and CD90.2+, were used to study intraclonal competition. 
10,000 naive CD90.2+ DO11.10, identifi  ed as described by Kearney et al. 
(38), were injected into naive BALB/c or HA TCR transgenic RAG-
  defi  cient BALB/c mice, some of which were then injected intradermally 
with 5 μg of OVA peptide plus 1 μg of LPS. 6 d later, a second population 
of 104 CFSE-labeled CD90.1+ DO11.10 cells was injected intravenously 
into these mice. 6 d after this transfer, cervical lymph nodes were stained 
with APC-labeled anti-B220, anti-CD8α, and anti-CD11b (BD Biosci-
ences) (to exclude non–T cells), PE-labeled anti–KJ1-26 (Caltag), and 
PerCP-labeled anti-CD90.1 antibodies to distinguish the two populations 
of DO11.10 cells.
In some cases, TEa memory cells were generated in one set of recipients 
and then transferred to new naive recipients. For this purpose B6 mice that 
received 106 naive TEa cells were injected intradermally in the ear with 10 μg 
of EαRFP and LPS. 17 d later, cells from cervical lymph nodes of these mice 
were stained with biotin-labeled anti-CD90.2 antibody and a biotin-labeled 
cocktail of antibodies specifi  c for cells other than CD4+ T cells (provided 
with the Mouse CD4 T cell Isolation kit [Miltenyi]). Anti-biotin antibody-
labeled magnetic beads were then added and the cells were passed over a 
magnetized LS column. The cells that passed through the column were 
highly enriched for CD90.1+ TEa cells. Cells with a one to four or greater 
than six cell division history were then sorted from this enriched population. 
The fraction of “untouched” TEa cells in these populations were then deter-
mined from a small sample as described in the preceding paragraph. 2,000 
CFSE1–4 or CFSE>6 TEa cells were then injected intravenously into naive 
B6 recipients, some of which were injected 1 d later with 100 μg of EαRFP 
plus LPS intravenously.
The small number of sorted memory cells transferred required that an 
enrichment method be used to detect them in recipient mice. 1 d after trans-
fer, or 4 d after antigen injection, spleen and mesenteric, inguinal, cervical, 
axillary, and brachial lymph node cells from each recipient mouse were 
stained with biotin-labeled anti-CD90.1 antibody and then streptavidin-
coated magnetic beads (Miltenyi). The cells were then passed over magne-
tized LS columns (Miltenyi), and bound cells were collected. A small portion 
of each sample was removed for a viable cell count. The remaining cells in 
each sample were stained with biotin-labeled anti-CD90.1, PerCP-labeled 
streptavidin (BD Bioscience), PE-Cy7–labeled anti-CD4, APC-labeled anti-
CD62L (eBioscience), PE-labeled anti-TCR Vα2, and Pacifi  c blue–labeled 
anti-B220 (Caltag), anti-CD11b, and anti-CD8α antibodies (to exclude cells 
other than CD4+ T cells). Because calibration experiments (unpublished 
data) showed that the magnetic bead enrichment method captures all of the 
cells in the original sample, it was possible to calculate the total number of 
TEa cells in that sample by multiplying the percentage of CD4+, B220−, 
CD11b−, CD8α−, CD90.1+, TCR Vα2+ cells by the total number of all 
cells as determined by the viable count.
Flow cytometry was performed on a FACSCalibur or LSR II device 
(Beckson Dickinson) and analyzed using FlowJo software (Tree Star, Inc.). 
Sorting of CFSE-labeled CD4 T cells was performed on a FACSDiva or 
FACSAria (Beckson Dickinson) at the University of Minnesota Cancer 
Center Flow Core.
Detection of peptide–I-Ab complexes. 50 μg of EαRFP was injected 
intradermally into the ears of mice. At various times after injection, draining 
cervical lymph nodes were collected and treated with collagenase and EDTA 
as previously described (9, 39). Dendritic cells were then enriched from cell 
suspensions using anti-CD11c microbeads and LS columns (Miltenyi). Cells 
were stained with PE-Cy5.5–labeled anti-CD11c (Caltag), Pacifi  c blue–
  labeled B220 (BD Bioscience), biotin-labeled YAe antibody (27), and strepta-
vidin-conjugated PE-Cy7 (eBioscience) and analyzed by fl  ow cytometry.
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